No Data
No Data
Medical beauty stocks fell collectively. Among them, Jiangsu Wuzhong fell to a standstill, Aimeike fell more than 9%, Jingfeng Pharmaceutical fell more than 5%, Huadong Pharmaceutical, Betaini, and Guanhao Biotech fell more than 4%, and Teyi Pharmaceutica
Medical beauty stocks fell collectively. Among them, Jiangsu Wuzhong fell to a standstill, Aimeike fell more than 9%, Jingfeng Pharmaceutical fell more than 5%, Huadong Pharmaceutical, Betaini, and Guanhao Biotech fell more than 4%, and Teyi Pharmaceutical, Shuyu Pingmin, Changshan Pharmaceutical, and Dian Diagnosis fell more than 3%.
Express News | Today, a total of 21 companies lifted the ban on restricted shares. The market value of Bethany lifted the ban exceeded 10 billion dollars
Express News | A total of 58 companies lifted the ban on restricted shares this week, with Bethany, Suneng shares, and Chu Tianlong having the highest market capitalization
Cinda Securities: Steady growth in large domestic sunscreen products, focus on leading cosmetics companies with alpha opportunities
Advances in technology of domestic brands and accurate grasping of consumer trends will help domestic sunscreen products occupy more market share.
Bethany (300957): Embarking on a New Journey
Winona 2.0 era begins. Looking forward to new changes in 2024, Winona is expected to enter a new era of 2.0 skin health: further deepening basic research and further expansion of efficacy research, from soothing and repairing to advanced sensitive skin PLUS, for dry and itchy skin
Bethany (300957): Winona 2.0 starts, performance improvements can be expected
Guide to this report: The company's main brand, Winona, underwent a 2.0 strategic upgrade to expand Sensitive Skin Plus and open up room for brand improvement. Recently, the upgraded version of Special Cream 2.0 was launched, which combined with the optimization of the company's organizational team, which is expected to drive performance improvement. throws
No Data